![Jürg Ambühl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jürg Ambühl formerly worked at MetaGen Pharmaceuticals GmbH, as Chief Executive Officer, Affidea Group BV, as Director, Santhera Pharmaceuticals Holding AG, as Director from 2009 to 2012, and MSD Sharp & Dohme GmbH, as General Manager from 1987 to 1999.
Dr. Ambühl received his Masters Business Admin degree from INSEAD and doctorate degree from Swiss Federal Institute of Technology.
| Sociétés | Poste | Fin |
|---|---|---|
MSD Sharp & Dohme GmbH
 MSD Sharp & Dohme GmbH Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products & vaccines | Corporate Officer/Principal | 01/01/1999 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Directeur/Membre du Conseil | - |
MetaGen Pharmaceuticals GmbH | Directeur Général | - |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Affidea Group BV
Affidea Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MSD Sharp & Dohme GmbH
MSD Sharp & Dohme GmbH Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products & vaccines | Health Technology |
MetaGen Pharmaceuticals GmbH |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
